C a s e R e p o r t e137
I NTRO D U C TIO NParathyroid adenoma is a major cause of primary hyperparathyroidism, with an incidence of 80%-85%.(1) Currently, t he primar y me t ho d of t reat ment is parathyroidectomy. (2,3) This method of treatment, however, may not be possible when there is a high surgical risk or contraindication for surgery, or when the patient is reticent to undergo surgical procedures. The latter being a concern raised mainly by women due to the possibility of a resulting postoperative scar. Hence, in most cases, parathyroidectomy is only performed on selected patients.With the swift development of minimally invasive and highly specific techniques, percutaneous sonography-guided radiofrequency ablation (RFA) therapy has been steadily progressing and yielding good clinical results.(4-7) While RFA has been used as a reasonably effective method to treat some primary and secondary tumours of the thyroid,lung (5,6) and liver, (7) the procedure is not limited to these organs. This report describes our experience with RFA in the treatment of parathyroid adenoma, and aims to assess the safety, effectiveness and durability of this procedure for the treatment of parathyroid adenoma.
CA S E R EPO RT S Case 1A 50-year-old man presented to our hospital with a onemonth history of vomiting, general fatigue and bone pain. ABSTRACT Parathyroid adenoma is a major cause of primary hyperparathyroidism. Treatment usually involves the surgical removal of one or more parathyroid glands. However, specific localising techniques have boosted the development of nonsurgical, minimally invasive procedures, such as percutaneous radiofrequency ablation (RFA) under ultrasonographic guidance, which are gaining popularity as a method of treatment. This paper reports two male patients who presented with hypercalcaemia (highest serum calcium level 4.56 mmol/L and 4.57 mmol/L, respectively) and hyperparathyroidism (highest serum parathyroid hormone [PTH] level 772 ng/L and > 1,900 ng/L, respectively) due to solitary parathyroid adenoma. Four days after percutaneous RFA, the serum calcium levels in both patients decreased and PTH levels showed a significant decreasing trend. Both patients recovered well with normal levels of calcium and improvement of symptoms. Thus, we conclude that RFA may be a safe and effective therapeutic option in the treatment of parathyroid adenoma.
Keywords: hypercalcaemia, intervention, parathyroid adenoma, radiofrequency ablationSingapore Med J 2013; 54(7): e137-e140 doi: 10.11622/smedj.2013092 Tc-sestamibi scintigraphy images before radiofrequency ablation show increased uptake of the radionuclide in the middle right lobe of the thyroid gland.